Skip to content

RA Capital Healthcare Fund LP, Director at Artiva Biotherapeutics, bought ARTV on Jul 24, 2026

Data as of Oct 16

▲ BUY$413K41,319 shares at $9.99RA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.
Watch ARTV
Traded
Jul 24, 2026
Disclosed
Jul 28, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

RA Capital Healthcare Fund LP, Director at Artiva Biotherapeutics, bought ARTV on Jul 24, 2026TRADEDDISCLOSED
ARTVSimilar stocks (XLV — its sector index fund), rebased to ARTV's price on the disclosure day
ARTV since disclosure
−44.4%
Similar stocks (XLV) since disclosure
+5.6%
XLV — its sector index fund

Change in closing price from Jul 28, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
  2. ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
  3. ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
  4. ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
  5. ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade

See every trade on ARTV →